Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-27

FDA Approved: GLYCOPYRROLATE — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approves Lifestar Pharma LLC's original ANDA for glycopyrrolate, a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycopyrrolate (glycopyrrolate)

Snippet

ORIG AP for GLYCOPYRROLATE (GLYCOPYRROLATE)